STOCK TITAN

EyePoint (EYPT) CFO reports RSU vesting and tax withholding

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

EyePoint, Inc.’s Chief Financial Officer, Elston George, reported equity compensation activity involving restricted stock units and common shares. On January 6, 2026, 15,285 restricted stock units converted into 15,285 shares of common stock at an exercise price of $0.00, increasing his directly held common shares before withholding to 96,339.

On the same date, 4,487 of those common shares were withheld by the issuer at $16.86 per share to satisfy tax withholding obligations, rather than being sold in the market, leaving 91,852 common shares held directly. An additional 25,000 common shares are reported as held indirectly in a family trust for the benefit of his children, with the trust company as trustee and George disclaiming beneficial ownership of those securities.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Elston George

(Last) (First) (Middle)
C/O EYEPOINT, INC.
480 PLEASANT STREET, SUITE C400

(Street)
WATERTOWN MA 02472

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
EyePoint, Inc. [ EYPT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
01/06/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/06/2026 M 15,285 A $0.00 96,339 D
Common Stock 01/06/2026 F 4,487 D $16.86(1) 91,852 D
Common Stock 25,000 I By Family Trust(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0.00 01/06/2026 M 15,285 (3) (3) Common Stock 15,285 $0.00 0.00 D
Explanation of Responses:
1. No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units.
2. These securities are held in a trust for the benefit of the reporting person's children. JP Morgan Trust Company of Delaware is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
3. The restricted stock units vest in three ratable annual installments beginning January 6, 2024.
Remarks:
/s/ Ron Honig, Attorney-in-Fact 01/07/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did EyePoint (EYPT) report for its CFO?

EyePoint, Inc. reported that Chief Financial Officer Elston George had 15,285 restricted stock units convert into 15,285 shares of common stock on January 6, 2026, at an exercise price of $0.00 per share.

Were any EyePoint (EYPT) shares sold by the CFO in this Form 4?

No market sale occurred. The filing explains that 4,487 common shares were withheld by the issuer at $16.86 per share solely to satisfy tax withholding requirements related to the vesting of restricted stock units.

How many EyePoint (EYPT) shares does the CFO hold directly after the reported transactions?

After the reported equity compensation activity and tax share withholding, Chief Financial Officer Elston George directly holds 91,852 shares of common stock.

What is the status of EyePoint (EYPT) shares held through the family trust?

The Form 4 reports 25,000 common shares held indirectly in a family trust for the benefit of the reporting person’s children, with JP Morgan Trust Company of Delaware as trustee. The reporting person disclaims beneficial ownership of these securities.

How do the restricted stock units for EyePoint (EYPT) CFO vest?

The filing states that the reported restricted stock units vest in three ratable annual installments beginning on January 6, 2024, with the January 6, 2026 amount reflecting one of these installments.

What do the transaction codes M and F mean in this EyePoint (EYPT) Form 4?

Code M reflects the conversion of restricted stock units into common stock at an exercise price of $0.00, while code F indicates that shares were withheld by the issuer to cover tax obligations related to the vesting, rather than sold in the open market.

EyePoint

NASDAQ:EYPT

EYPT Rankings

EYPT Latest News

EYPT Latest SEC Filings

EYPT Stock Data

1.31B
77.72M
3.51%
101.33%
12.26%
Biotechnology
Laboratory Analytical Instruments
Link
United States
WATERTOWN